Analyst Recommendations
241.13 6.37(2.71%)09/13/2024
Madrigal Pharmaceuticals Inc (MDGL)
Madrigal Pharmaceuticals Inc (MDGL)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 9 |
Outperform | 6 |
Market Outperform | 4 |
Neutral | 2 |
Overweight | 2 |
Sell | 2 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades